3 ações de saúde de alto rendimento para comprar com US$ 1.000 e manter em qualquer mercado

Current dividend yields on major U.S. stock market indexes aren't particularly high. For instance, the S&P 500's yield is 1.1% as of writing, which is well below its long-term average. Thankfully, there are attractive dividend stocks to consider buying that boast much higher yields. Here are three examples: Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and Medtronic (NYSE: MDT). For income investors with $1,000 to spare, here's why it's worth it to put that money into one -- or all three -- of these dividend stocks. Image source: The Motley Fool. Pfizer has encountered challenges over the past few years that have put downward pressure on its stock. Consequently, the company's dividend yield has increased. Pfizer currently boasts a juicy forward yield of 5.7%, well above the S&P 500 average. Of course, this doesn't mean much if the drugmaker's challenges lead to payout cuts in the near future. But that's unlikely to happen. Pfizer has not reduced its dividends despite the challenges it has encountered over the past few years. The company is also slowly making progress in overcoming its obstacles.

CryptoAlerta — análise de criptomoedas e mercado em tempo real